These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
466 related articles for article (PubMed ID: 32703771)
1. Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis. Armstrong-James D; Youngs J; Bicanic T; Abdolrasouli A; Denning DW; Johnson E; Mehra V; Pagliuca T; Patel B; Rhodes J; Schelenz S; Shah A; van de Veerdonk FL; Verweij PE; White PL; Fisher MC Eur Respir J; 2020 Oct; 56(4):. PubMed ID: 32703771 [TBL] [Abstract][Full Text] [Related]
2. Fungal Infections in COVID-19-Positive Patients: A Lack of Optimal Treatment Options. Silva LN; de Mello TP; de Souza Ramos L; Branquinha MH; Roudbary M; Dos Santos ALS Curr Top Med Chem; 2020; 20(22):1951-1957. PubMed ID: 33040728 [No Abstract] [Full Text] [Related]
3. Dynamic Immune Response Profiles and Recovery of a COVID-19 Patient with Coinfection of Wu S; Yang S; Chen R; Chen H; Xu Y; Lin B OMICS; 2020 Oct; 24(10):615-618. PubMed ID: 32905742 [No Abstract] [Full Text] [Related]
4. Impact of negative air pressure in ICU rooms on the risk of pulmonary aspergillosis in COVID-19 patients. Ichai P; Saliba F; Baune P; Daoud A; Coilly A; Samuel D Crit Care; 2020 Sep; 24(1):538. PubMed ID: 32867810 [No Abstract] [Full Text] [Related]
5. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion. Verweij PE; Rijnders BJA; Brüggemann RJM; Azoulay E; Bassetti M; Blot S; Calandra T; Clancy CJ; Cornely OA; Chiller T; Depuydt P; Giacobbe DR; Janssen NAF; Kullberg BJ; Lagrou K; Lass-Flörl C; Lewis RE; Liu PW; Lortholary O; Maertens J; Martin-Loeches I; Nguyen MH; Patterson TF; Rogers TR; Schouten JA; Spriet I; Vanderbeke L; Wauters J; van de Veerdonk FL Intensive Care Med; 2020 Aug; 46(8):1524-1535. PubMed ID: 32572532 [TBL] [Abstract][Full Text] [Related]
6. COVID-19-associated pulmonary aspergillosis in a tertiary care center in Shenzhen City. Jiang Z; Chen S; Zhu Q; Xiao Y; Qu J J Infect Public Health; 2022 Feb; 15(2):222-227. PubMed ID: 35032951 [TBL] [Abstract][Full Text] [Related]
7. Subacute Aspergillosis "Fungal Balls" Complicating COVID-19. Patti RK; Dalsania NR; Somal N; Sinha A; Mehta S; Ghitan M; Seneviratne C; Kupfer Y J Investig Med High Impact Case Rep; 2020; 8():2324709620966475. PubMed ID: 33054445 [TBL] [Abstract][Full Text] [Related]
9. Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective. Halpin DMG; Singh D; Hadfield RM Eur Respir J; 2020 May; 55(5):. PubMed ID: 32341100 [TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics of invasive pulmonary aspergillosis in patients with COVID-19 in Zhejiang, China: a retrospective case series. Wang J; Yang Q; Zhang P; Sheng J; Zhou J; Qu T Crit Care; 2020 Jun; 24(1):299. PubMed ID: 32503617 [No Abstract] [Full Text] [Related]
11. Coinfection of pneumocystis jiroveci pneumonia and pulmonary aspergillosis in a non-HIV-infected patient. Lee PH; Fu PK J Microbiol Immunol Infect; 2018 Dec; 51(6):860-861. PubMed ID: 30473143 [No Abstract] [Full Text] [Related]
12. COVID-19: The Uninvited Guest in the Intensive Care Unit - Implications for Pharmacotherapy. Stringer KA; Puskarich MA; Kenes MT; Dickson RP Pharmacotherapy; 2020 May; 40(5):382-386. PubMed ID: 32267979 [No Abstract] [Full Text] [Related]
13. Invasive aspergillosis in coronavirus disease 2019: a practical approach for clinicians. Lamoth F Curr Opin Infect Dis; 2022 Apr; 35(2):163-169. PubMed ID: 34980831 [TBL] [Abstract][Full Text] [Related]
14. Fungal co-infection in COVID-19 patients: Should we be concerned? Pemán J; Ruiz-Gaitán A; García-Vidal C; Salavert M; Ramírez P; Puchades F; García-Hita M; Alastruey-Izquierdo A; Quindós G Rev Iberoam Micol; 2020; 37(2):41-46. PubMed ID: 33041191 [TBL] [Abstract][Full Text] [Related]
15. COVID-19 associated with pulmonary aspergillosis: A literature review. Lai CC; Yu WL J Microbiol Immunol Infect; 2021 Feb; 54(1):46-53. PubMed ID: 33012653 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach. Sarma P; Prajapat M; Avti P; Kaur H; Kumar S; Medhi B Indian J Pharmacol; 2020; 52(1):1-5. PubMed ID: 32201439 [No Abstract] [Full Text] [Related]
17. Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis. Verweij PE; Brüggemann RJM; Azoulay E; Bassetti M; Blot S; Buil JB; Calandra T; Chiller T; Clancy CJ; Cornely OA; Depuydt P; Koehler P; Lagrou K; de Lange D; Lass-Flörl C; Lewis RE; Lortholary O; Liu PL; Maertens J; Nguyen MH; Patterson TF; Rijnders BJA; Rodriguez A; Rogers TR; Schouten JA; Wauters J; van de Veerdonk FL; Martin-Loeches I Intensive Care Med; 2021 Aug; 47(8):819-834. PubMed ID: 34160631 [TBL] [Abstract][Full Text] [Related]
18. How likely are COVID-19 interventions to benefit the sickest patients? Perner A; Tirupakuzhi Vijayaraghavan BK; Venkatesh B Intensive Care Med; 2020 Jul; 46(7):1441-1444. PubMed ID: 32519004 [No Abstract] [Full Text] [Related]
19. Audio Interview: Dexamethasone and Covid-19. Rubin EJ; Baden LR; Morrissey S N Engl J Med; 2020 Jul; 383(4):e52. PubMed ID: 32706553 [No Abstract] [Full Text] [Related]
20. Navigating the Uncertainties of COVID-19-Associated Aspergillosis: A Comparison With Influenza-Associated Aspergillosis. Lamoth F; Lewis RE; Walsh TJ; Kontoyiannis DP J Infect Dis; 2021 Nov; 224(10):1631-1640. PubMed ID: 33770176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]